Liraglutide: all 338 studies that test it

Page 1 of 4. Open to participants first (20), then studies with results posted, then the rest; newest registration first within each.

• Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic ControlRecruitingNCT07244003Phase 4
• Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)RecruitingNCT07225816Phase 1
• Liraglutide Treatment in Patients With Maturity-onset Diabetes of the Young (MODY)RecruitingNCT07029009Phase 2
• The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 DiabetesRecruitingNCT06976619Phase 2
• Liraglutide Treatment in Obese Infertile PCOS WomenRecruitingNCT06742710Phase 4
• A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 DiabetesNot yet recruitingNCT06559722Phase 3
• Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver DiseaseRecruitingNCT06501326Phase 4
• A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide in Healthy Chinese SubjectsRecruitingNCT06449703Phase 1
• LIROH - Liraglutide for Obesity in HIVRecruitingNCT06438146Phase 4
• Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac SurgeryRecruitingNCT06361238Phase 3
• The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot StudyRecruitingNCT06217848Early Phase 1
• Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and InfertilityNot yet recruitingNCT05952882Phase 3
• Effects of GLP-1RA on Body Weight, Metabolism and Fat Distribution in Overweight/Obese Patients With Type 2 Diabetes MellitusRecruitingNCT05779644Not applicable
• POSE2.0 With GLP-1 Agonist for Obesity ManagementRecruitingNCT05705388Not applicable
• Effects of GH and Lirglutide on AgRPRecruitingNCT05681299Phase 4
• Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes MellitusRecruitingNCT05268237Phase 1/2
• Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic SyndromeRecruitingNCT04575844Phase 4
• Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)RecruitingNCT03883412Phase 4
• Liraglutide-bolus vs Glargine-bolus Therapy in Overweight/Obese Type 2 Diabetes Patients (LiraGooD)RecruitingNCT03087032Phase 4
• Safety and Efficacy of Umbilical Cord Blood Regulatory T Cells Plus Liraglutide on Autoimmune DiabetesRecruitingNCT03011021Phase 1/2
• Safety, Tolerability and Pharmacokinetics of Intraarticular 4P004 Single Dose in Patient With KL 2-4 Osteoarthritic KneeCompletedNCT05419856Phase 1Results posted
• Liraglutide (Saxenda(R)) in Adolescents With Obesity After Sleeve GastrectomyCompletedNCT04883346Phase 2Results posted
• Liraglutide and Peripheral Artery DiseaseCompletedNCT04881110Phase 4Results posted
• Efficacy of Liraglutide Therapy in Patients With IPAATerminatedNCT04763564Phase 2Results posted
• EMI-EHP Weight Management and Type 2 Diabetes Pragmatic TrialTerminatedNCT04531176Phase 4Results posted
• Use of a GLP-1R Agonist to Treat Opioid Use DisorderCompletedNCT04199728Phase 1/2Results posted
• Multiple Ascending Dose Study of AMG 598 in Adults With ObesityCompletedNCT03757130Phase 1Results posted
• Daily Liraglutide for Nicotine DependenceCompletedNCT03712098Phase 2Results posted
• Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in ObesityCompletedNCT03523273Phase 2Results posted
• Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.TerminatedNCT03500484Early Phase 1Results posted
• Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOSCompletedNCT03480022Phase 3Results posted
• Binge Eating Liraglutide InterventionTerminatedNCT03279731Phase 3Results posted
• Liraglutide Effects on Epicardial Fat Inflammatory GenesCompletedNCT03260881Phase 4Results posted
• A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)CompletedNCT03175120Phase 3Results posted
• A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)CompletedNCT03172494Phase 3Results posted
• Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)CompletedNCT03158805Phase 2Results posted
• Effect of GLP-1 Receptor Agonism After Sleeve GastrectomyCompletedNCT03115424Phase 3Results posted
• Cardiovascular Effects of GLP-1 Receptor ActivationCompletedNCT03101930Phase 4Results posted
• Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass SurgeryCompletedNCT03048578Phase 4Results posted
• Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese SubjectsCompletedNCT03041792Phase 1Results posted
• Impact of Liraglutide 3.0 on Body Fat DistributionCompletedNCT03038620Phase 4Results posted
• Saxenda in Obesity Services (STRIVE Study)CompletedNCT03036800Phase 4Results posted
• Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes MellitusCompletedNCT03010683Not applicableResults posted
• LIRA-ADD2SGLT2i - Liraglutide Versus Placebo as add-on to SGLT2 Inhibitors.CompletedNCT02964247Phase 3Results posted
• Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist SettingCompletedNCT02963935Phase 3Results posted
• Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal InsulinCompletedNCT02963922Phase 3Results posted
• Title: Therapeutic Targets in African-American Youth With Type 2 DiabetesCompletedNCT02960659Phase 1/2Results posted
• Safety and Efficacy of Liraglutide in Parkinson's DiseaseCompletedNCT02953665Phase 2Results posted
• Effect of Liraglutide for Weight Management in Pubertal Adolescent Subjects With ObesityCompletedNCT02918279Phase 3Results posted
• A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre-mix/Combination Insulin Therapy and Oral Anti-diabetic DrugsCompletedNCT02911948Phase 3Results posted
• Lifestyle Modification and LiraglutideCompletedNCT02911818Phase 4Results posted
• Study to Assess the Efficacy of Liraglutide in Patients With Type 2 Diabetes MellitusCompletedNCT02889510Phase 3Results posted
• Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 DiabetesCompletedNCT02777073Not applicableResults posted
• A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes MellitusCompletedNCT02773368Phase 3Results posted
• The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo LipogenesisCompletedNCT02765399Phase 4Results posted
• Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 DiabetesCompletedNCT02730377Phase 4Results posted
• Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in ObesityCompletedNCT02647944Phase 2Results posted
• A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.CompletedNCT02607306Phase 3Results posted
• Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi SyndromeCompletedNCT02527200Phase 3Results posted
• Liraglutide in Adolescents With Type 1 DiabetesCompletedNCT02516657Phase 3Results posted
• A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.CompletedNCT02505334Phase 3Results posted
• A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes MellitusCompletedNCT02501161Phase 3Results posted
• A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell FunctionCompletedNCT02443155Phase 2Results posted
• A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes MellitusCompletedNCT02420262Phase 3Results posted
• Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic PatientsCompletedNCT02324842Not applicableResults posted
• A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration AlgorithmsCompletedNCT02298192Phase 3Results posted
• The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 DiabetesCompletedNCT02098395Phase 3Results posted
• A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)TerminatedNCT02072096Phase 4Results posted
• Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 DiabetesCompletedNCT02014740Phase 4Results posted
• The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 DiabetesCompletedNCT02008682Phase 4Results posted
• Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 DiabetesCompletedNCT01973231Phase 4Results posted
• The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE StudyCompletedNCT01966978Phase 4Results posted
• A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide Versus Insulin Glargine in Subjects With Type 2 Diabetes MellitusCompletedNCT01952145Phase 3Results posted
• Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2DCompletedNCT01937598Phase 3Results posted
• Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 DiabetesCompletedNCT01917656Phase 4Results posted
• Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and MetforminCompletedNCT01907854Phase 4Results posted
• A Study of LY3025876 in Participants With DiabetesCompletedNCT01870297Phase 1Results posted
• Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 DiabetesCompletedNCT01856790Early Phase 1Results posted
• The Effect of Glucagon-like-peptide 1 (GLP-1) Receptor Agonism on Diabetic Kidney DiseaseCompletedNCT01847313Phase 3Results posted
• The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 DiabetesCompletedNCT01836523Phase 3Results posted
• A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 WeeksCompletedNCT01832532Phase 1/2Results posted
• Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)CompletedNCT01800968Phase 2Results posted
• 52 Week Trial of Liraglutide in Type 1 DiabetesCompletedNCT01787916Phase 4Results posted
• Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.CompletedNCT01784965Phase 3Results posted
• RISE Adult Medication StudyCompletedNCT01779362Phase 3Results posted
• Liraglutide Versus Insulin Mono-therapy in the Closed Loop SettingCompletedNCT01755416Phase 2Results posted
• Liraglutide In Overweight Patients With Type 1 DiabetesCompletedNCT01753362Phase 3Results posted
• Liraglutide in the Treatment of Type 1 Diabetes MellitusCompletedNCT01722266Phase 3Results posted
• Liraglutide in Type 1 DiabetesCompletedNCT01722240Phase 3Results posted
• The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD TherapyCompletedNCT01676116Phase 3Results posted
• Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal ImpairmentCompletedNCT01620489Phase 3Results posted
• The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin TherapyCompletedNCT01618162Phase 3Results posted
• The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 DiabetesCompletedNCT01617434Phase 3Results posted
• Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 DiabetesCompletedNCT01572740Phase 3Results posted
• Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRICompletedNCT01562678Phase 4Results posted
• Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea: SCALE™ - Sleep ApnoeaCompletedNCT01557166Phase 3Results posted
• Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 DiabetesCompletedNCT01541215Phase 3Results posted
• Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD AloneCompletedNCT01512108Phase 3Results posted
• Adding Liraglutide to High Dose Insulin: Breaking the CycleCompletedNCT01505673Phase 4Results posted
• A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 DiabetesCompletedNCT01392573Phase 3Results posted

← Liraglutide overview